SCICLONE PHARMACEUTICALS, INC. EMPLOYEE RETENTION AGREEMENTEmployee Retention Agreement • November 9th, 2015 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations • California
Contract Type FiledNovember 9th, 2015 Company Industry JurisdictionThis Employee Retention Agreement (the “Agreement”) is effective as of July 31, 2015, by and between Hong Zhao (“Employee”), SciClone Pharmaceuticals (China) Co., Ltd., a People’s Republic of China limited liability company, and SciClone Pharmaceuticals, Inc., a Delaware corporation (together, the “Company”). For all purposes under this Agreement, the term “Company” shall include any successor to the Company’s business and/or assets, or any subsidiary of the Company or its successor.
SCICLONE PHARMACEUTICALS, INC. EMPLOYEE RETENTION AGREEMENTEmployee Retention Agreement • November 9th, 2015 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations • California
Contract Type FiledNovember 9th, 2015 Company Industry JurisdictionThis Employee Retention Agreement (the “Agreement”) is effective as of July 31, 2015, by and between Lan Xie (“Employee”), SciClone Pharmaceuticals (China) Co., Ltd., a People’s Republic of China limited liability company, SciClone Pharmaceuticals Hong Kong Limited, a Hong Kong limited liability company, and SciClone Pharmaceuticals, Inc., a Delaware corporation (together, the “Company”). For all purposes under this Agreement, the term “Company” shall include any successor to the Company’s business and/or assets, or any subsidiary of the Company or its successor.
SCICLONE PHARMACEUTICALS, INC. EMPLOYEE RETENTION AGREEMENTEmployee Retention Agreement • November 9th, 2015 • Sciclone Pharmaceuticals Inc • Pharmaceutical preparations • California
Contract Type FiledNovember 9th, 2015 Company Industry JurisdictionThis Employee Retention Agreement (the “Agreement”) is effective as of July 31, 2015, by and between Meng Chun Cai (“Employee”), SciClone Pharmaceuticals (China) Co., Ltd., a People’s Republic of China limited liability company, SciClone Pharmaceuticals Hong Kong Limited, a Hong Kong limited liability company, and SciClone Pharmaceuticals, Inc., a Delaware corporation (together, the “Company”). For all purposes under this Agreement, the term “Company” shall include any successor to the Company’s business and/or assets, or any subsidiary of the Company or its successor.